CryoFluor Therapeutics LLC
This article was originally published in Start Up
Executive Summary
Rather than using a probe or balloon to deliver energy-based endometrial ablation, CryoFluor Therapeutics LLC uses a liquid as the cryogenic medium. By fully conforming to the surface of the uterus, the liquid cryogen ablates more completely, and the company believes that it is also better suited than probe-based devices for treating women with irregularly shaped uteri or abnormal uterine tissue.